These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 3108910

  • 1. Involvement of a dopaminergic mechanism in the response of growth hormone to thyrotropin releasing hormone in patients with major depression.
    Marchesi C, Gnudi A, Chiodera P, De Risio C, Fava A, Dasso L, De Ferri A, Guerra M, Coiro V.
    Pharmacopsychiatry; 1987 Mar; 20(2):64-6. PubMed ID: 3108910
    [Abstract] [Full Text] [Related]

  • 2. Non-specific response of serum growth hormone to thyrotropin-releasing hormone in diabetics.
    Pan CY, Lu JM, Chang XM, Luo GC, Li H.
    Chin Med J (Engl); 1989 Jan; 102(1):41-4. PubMed ID: 2504551
    [Abstract] [Full Text] [Related]

  • 3. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Iacona T, Conte G, Fabrizi ML, Valle D, Anile C, Maira G.
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Conte G, Sammartano L, Fabrizi ML, Valle D.
    Exp Clin Endocrinol Diabetes; 1996 Nov; 104(1):67-71. PubMed ID: 8750573
    [Abstract] [Full Text] [Related]

  • 6. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP, Jacobs LS, Hoffman W, Daughaday WH, Blizzard RM.
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [Abstract] [Full Text] [Related]

  • 7. Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH.
    Coiro V, Volpi R, Cataldo S, Capretti L, Caffarri G, Pilla S, Chiodera P.
    J Investig Med; 2000 Mar; 48(2):133-6. PubMed ID: 10736973
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF, van Liessum PA, Smals AG, van Gennep JA, Benraad TJ, Kloppenborg PW.
    Acta Endocrinol Suppl (Copenh); 1987 Mar; 286():9-18. PubMed ID: 2892339
    [Abstract] [Full Text] [Related]

  • 9. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E, Kartalci S, Tutus A, Turan T, Sofuoglu S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V, Nedvídková J.
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract] [Full Text] [Related]

  • 13. TRH-induced growth hormone release in insulin-dependent diabetes mellitus.
    Krassowski J, Jeske W, Zgliczyński S.
    Horm Metab Res; 1984 Dec; 16 Suppl 1():119-22. PubMed ID: 6442706
    [Abstract] [Full Text] [Related]

  • 14. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP, Owings J, Hayford JT, Blizzard RM.
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [Abstract] [Full Text] [Related]

  • 15. Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response.
    Winokur A, Caroff SN, Amsterdam JD, Maislin G.
    Biol Psychiatry; 1984 May; 19(5):695-702. PubMed ID: 6428472
    [Abstract] [Full Text] [Related]

  • 16. The effect of TRH, cyproheptadine and pimozide on the growth hormone response to intramuscular glucagon.
    Hainer V, Urbánek J, Malec B, Krejcik L.
    Horm Metab Res; 1981 Aug; 13(8):451-3. PubMed ID: 6799379
    [Abstract] [Full Text] [Related]

  • 17. The growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics involves a cholinergic mechanism.
    Chiodera P, Coiro V, Speroni G, Capretti L, Muzzetto P, Volpi R, Butturini U.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):794-7. PubMed ID: 6434581
    [Abstract] [Full Text] [Related]

  • 18. Dopaminergic control of TSH secretion in endogenous depression.
    Marchesi C, Chiodera P, De Risio C, Dassò L, Govi AM, De Ferri A, Piagneri B, Minelli R, Bianconi L, Gnudi A.
    Psychiatry Res; 1988 Sep; 25(3):277-82. PubMed ID: 3141942
    [Abstract] [Full Text] [Related]

  • 19. Pirenzepine inhibits growth hormone, but not thyrotropin response to thyrotropin-releasing hormone in patients with endogenous depression.
    Coiro V, Marchesi C, De Ferri A, Mosti A, Delsignore R, Govi AM, Gnudi A, Chiodera P.
    Psychoneuroendocrinology; 1987 Sep; 12(4):313-7. PubMed ID: 3116574
    [Abstract] [Full Text] [Related]

  • 20. Is there paradoxical growth hormone response to thyrotropin-releasing hormone in depression?
    Hsiao JK, Garbutt JC, Loosen PT, Mason GA, Prange AJ.
    Biol Psychiatry; 1986 Jun; 21(7):595-600. PubMed ID: 3085739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.